Researchers Finding Rewarding Careers As Software Entrepreneurs

Entrepreneurs When Steve Sands was studying for his Ph.D. in neuroscience in the late 1970s, he planned to write his doctoral thesis on experiments matching brain function with behavior. However, a lack of good software or computerized methods for correlating brain activity with behavior eventually forced Sands to drop his idea. "I ended up doing a thesis on animal behavior [alone] rather than the neuroscience project I really wanted to do," he recalls. Like many scientists who are frustrated

Written byLee Katterman
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Entrepreneurs When Steve Sands was studying for his Ph.D. in neuroscience in the late 1970s, he planned to write his doctoral thesis on experiments matching brain function with behavior. However, a lack of good software or computerized methods for correlating brain activity with behavior eventually forced Sands to drop his idea. "I ended up doing a thesis on animal behavior [alone] rather than the neuroscience project I really wanted to do," he recalls.

Like many scientists who are frustrated by the lack of available software tools to aid in specific experiments, Sands took up programming while he was working on the psychology department faculty at the University of Texas, El Paso. And like a number of these computer-savvy researchers, Sands eventually was able to parlay this experience into a new career: He wrote a pair of software programs tailored to neuroscience research that he took to market.

Today, he is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies